Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 100 of 129

TitleReference numberPublishedLast updated
Dapagliflozin for treating chronic kidney diseaseTA775
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Prontosan for treating acute and chronic woundsMTG67
3C Patch for treating diabetic foot ulcersMTG66
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Intramedullary distraction for lower limb lengtheningIPG718
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Mental wellbeing at workNG212
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseDG45
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
The Insides System for managing intestinal failureMIB286
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
d-Nav insulin management app for type 2 diabetesMIB285
Stereotactic radiosurgery for trigeminal neuralgiaIPG715
Microwave ablation for primary or metastatic cancer in the lungIPG716
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)TA762
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Fremanezumab for preventing migraineTA764
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Palforzia for treating peanut allergy in children and young peopleTA769
Colorectal cancerQS20
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careMTG65
Glaucoma: diagnosis and managementNG81
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resectionTA761
Rehabilitation after traumatic injuryNG211
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA760
Smart Peak Flow for monitoring asthmaMIB282
Cabotegravir with rilpivirine for treating HIV-1TA757
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Prostate cancerQS91
Headaches in over 12s: diagnosis and managementCG150
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
Transanal total mesorectal excision for rectal cancerIPG713
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
Colorectal cancerNG151
Prostate cancer: diagnosis and managementNG131
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Cenobamate for treating focal onset seizures in epilepsyTA753
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754

Results per page

  1. 10
  2. 25
  3. 50
  4. All